- Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects2018 | Second Faculty of Medicine
- Avelumab plus axitinib combination in treating metastatic renal cell carcinoma2022 | First Faculty of Medicine
- Immunotherapy of pulmonary carcinoma2015 | Publication without faculty affiliation
- Position of adjuvant therapy in the therapy of melanoma2018 | First Faculty of Medicine
- Diabetes mellitus and molecular genetic consequences2006 | Second Faculty of Medicine
- BRAF mutation: a novel approach in targeted melanoma therapy2012 | Third Faculty of Medicine
- CD80 Expression on Tumor Cells Alters Tumor Microenvironment and Efficacy of Cancer Immunotherapy by CTLA-4 Blockade2021 | Faculty of Science
- Insomnia in patients treated with checkpoint inhibitors for cancer: A meta-analysis2022 | First Faculty of Medicine
- The CTLA4 variants may interact with the IL23R-and NOD2-conferred risk in development of Crohn's disease2010 | Second Faculty of Medicine